Abstract
The epigenetic remodeling of chromatin through histone modifications has been widely implicated in drug resistance of cancer cells. However, whether epigenetic mechanisms contribute specifically to doxorubicin resistance in leukemia has not been carefully examined. Using a stable and sensitive workflow based on LC-MS, we quantitatively compared the extents of methylation and acetylation of histone H3 and H4 in acute leukemia cell line HL60 and its doxorubicin-resistant derivative, HL60/ADR, as well as the chronic leukemia cell line K562 and its doxorubicin-resistant derivative, K562/ADR. We found that increased levels of H3K9 methylation, H3K14, H3K18 and H3K23 acetylation, and potentially H4K20 methylation, are associated with drug resistance in both cells. Our results demonstrated that the doxorubicin-resistant acute and chronic leukemia cell lines may share a common epigenetic mechanism that involves a combination of transcriptional activation and silencing.
References
Dec 4, 1992·Science·S P ColeR G Deeley
Jan 18, 1989·Journal of the National Cancer Institute·L J GoldsteinG M Brodeur
Jun 11, 1998·The Journal of Biological Chemistry·H WaliaJ R Davie
Oct 31, 2000·Current Opinion in Hematology·A K BurnettC Rowntree
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
Mar 15, 2005·Nature Genetics·Mario F FragaManel Esteller
Jun 21, 2005·The International Journal of Biochemistry & Cell Biology·Lucia AltucciHinrich Gronemeyer
Dec 13, 2006·Current Opinion in Chemical Biology·Benjamin A GarciaDonald F Hunt
Feb 27, 2007·Cell·Tony Kouzarides
Mar 17, 2007·Molecular Cancer Therapeutics·Vasyl' F ChekhunIgor P Pogribny
Apr 5, 2007·Nature Protocols·Hermann Schägger
Apr 21, 2007·Nature Protocols·Benjamin A GarciaDonald F Hunt
Jun 5, 2007·Nature Protocols·David ShechterSandra B Hake
Aug 19, 2007·Rapid Communications in Mass Spectrometry : RCM·Le-Heng WangWen Gao
May 12, 2010·MAbs·Hongwei XieJeffery R Mazzeo
Jan 12, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alan BurnettBob Löwenberg
Sep 20, 2011·Cell·Minjia TanYingming Zhao
May 16, 2012·Methods in Molecular Biology·Syed R HaiderBarry L Sharp
Jul 25, 2012·Molecular Pharmacology·Cindy Q Xia, Peter G Smith
Aug 23, 2012·Methods in Enzymology·Shu Lin, Benjamin A Garcia
Sep 8, 2012·Advances in Experimental Medicine and Biology·Curt Balch, Kenneth P Nephew
Jan 26, 2013·Current Opinion in Cell Biology·Tanja Waldmann, Robert Schneider
Feb 12, 2013·Bioanalysis·Wenyan WangPengyuan Yang
Mar 21, 2013·BMC Genomics·Brian J AbrahamKeji Zhao
Feb 28, 2014·Journal of Cellular and Molecular Medicine·Hongjie ShenYan Chen
Dec 24, 2014·Immunology and Cell Biology·Ian A MacDonald, Nathaniel A Hathaway
Dec 24, 2014·Nature Reviews. Immunology·Damiana Álvarez-ErricoEsteban Ballestar